I mean - script support is a big deal for a lot of use cases. I think the other big thing is that unlike Free, you can buy Home for other architectures (although only some and not all other architectures, another incredible mystery).
I'd buy Home if it came in C167, not because I want to but because $365/year is still a lot less time than I'd spend writing/finishing a C167 module for Ghidra.
Anyway, the pricing model doesn't actually make any sense no matter how you slice it, and this latest announcement is even more bizarre. I really wonder how long for this world Hex-Rays products are, the always glacial development pace is still quite slow and as a new generation of people start by using Ghidra, there will IMO be less drive to buy corporate IDA renewals going forward.
I'd buy Home if it came in C167, not because I want to but because $365/year is still a lot less time than I'd spend writing/finishing a C167 module for Ghidra.
Anyway, the pricing model doesn't actually make any sense no matter how you slice it, and this latest announcement is even more bizarre. I really wonder how long for this world Hex-Rays products are, the always glacial development pace is still quite slow and as a new generation of people start by using Ghidra, there will IMO be less drive to buy corporate IDA renewals going forward.